Solvay SA Says Mulling Options For Drugs Unit
AMSTERDAM, April 1 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay (SOLB.BR) said on Wednesday it is analysing various options for its pharmaceutical activities and may enter talks with various third parties about the business.